(Q33888577)

29 July 2017

1 reference

title

Therapeutic drug monitoring of psychotropic medications. (English)

1 reference

29 July 2017

P B Mitchell

1

1 reference

PubMed ID

10759685

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

British Journal of Clinical Pharmacology

29 July 2017

1 reference

29 July 2017

49

1 reference

29 July 2017

303-312

1 reference

29 July 2017

4

1 reference

Lithium salts in the treatment of psychotic excitement

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Use of lithium salts as a substitute for sodium chloride

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Therapeutic drug monitoring in drug overdose.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Prediction of valproate serum concentrations in adult psychiatric patients using Bayesian model estimations with NPEM2 population pharmacokinetic parameters

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Fundamentals and applications of pharmacogenetics for the clinical laboratory.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

The ups and downs of oral lithium dosing

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Compliance with medication regimens for mental and physical disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Drug interactions of clinical significance with selective serotonin reuptake inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high-performance liquid chromatography with electrochemical detection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Will routine therapeutic drug monitoring have a place in clozapine therapy?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

The use of antidepressants and therapeutic drug monitoring by general practitioners and psychiatrists: findings from a questionnaire survey in two Swedish areas.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Serum lithium levels and psychosocial function in patients with bipolar I disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Clinical relevance of drug interactions with lithium

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Clinical pharmacokinetics of lithium

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Clinical pharmacokinetics of antipsychotics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Imipramine metabolism in relation to the sparteine and mephenytoin oxidation polymorphisms--a population study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Cytochrome P4502D6 genotype does not determine response to clozapine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

The 24-hour serum lithium level as a prognosticator of dosage requirements.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Lithium intoxication: clinical course and therapeutic considerations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Methodologies for antidepressant monitoring.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Clinical features and management of lithium poisoning

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Therapeutic drug monitoring of tricyclic antidepressants

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Bupropion in depression. II. The role of metabolites in clinical outcome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

The meaning of serum lithium levels in maintenance therapy of mood disorders: a review of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Therapeutic monitoring of antidepressant drugs: guidelines updated

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Lithium prophylaxis: myths and realities

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Neuroleptic Plasma Levels

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

ABC of monitoring drug therapy. Lithium

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Brain lithium concentration by 7Li- and 1H-magnetic resonance spectroscopy in bipolar disorder.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Severe lithium toxicity with "normal" serum concentrations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Patient and physician attitudes toward lithium: relationship to compliance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Dosage adjustment from simple nortriptyline spot level predictor tests in depressed patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

CYP2D6 genotype determination in the Danish population.

5 July 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00174.X

Clinical and Serum-Level Monitoring in Lithium Therapy and Lithium Intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00174.X

Duration of lithium treatment and brain lithium concentration in patients with unipolar and schizoaffective disorder--a study with magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00174.X

In vivo 7Li nuclear magnetic resonance study of lithium pharmacokinetics and chemical shift imaging in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00174.X

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00174.X

The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2000.00174.X

Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014933

Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges

29 October 2018

1 reference

12 December 2020

Solid-phase extraction and high-performance liquid chromatographic analysis of clozapine and norclozapine in human plasma

1 reference

12 December 2020

Therapeutic drug monitoring of risperidone and 9-hydroxyrisperidone in serum with solid-phase extraction and high-performance liquid chromatography

1 reference

12 December 2020

Standards of laboratory practice: antidepressant drug monitoring. National Academy of Clinical Biochemistry

1 reference

12 December 2020

Therapeutic drug monitoring--antiepileptic drugs

1 reference

12 December 2020

Drug interactions with newer antidepressants: role of human cytochromes P450

1 reference

12 December 2020

Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels

1 reference

12 December 2020

Three-year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levels

1 reference

12 December 2020

Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

1 reference

12 December 2020

Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium

1 reference

12 December 2020

Drug level monitoring: antidepressants

1 reference

12 December 2020

The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders

1 reference

12 December 2020

Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking

1 reference

12 December 2020

Haloperidol: therapeutic window in schizophrenia

1 reference

12 December 2020

Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study

1 reference

12 December 2020

Polymorphic drug metabolism in schizophrenic patients with tardive dyskinesia

1 reference

12 December 2020

Relationship of lithium chloride dose to treatment response in acute mania

1 reference

12 December 2020

Drug-Metabolizing Enzymes and Therapeutic Drug Monitoring in Psychiatry

1 reference

12 December 2020

Lithium Prophylaxis in Recurrent Affective Disorders

1 reference

12 December 2020

Nortriptyline plasma levels and therapeutic response

1 reference

12 December 2020

Desipramine plasma concentration and antidepressant response

1 reference

12 December 2020

Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder

1 reference

12 December 2020

Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response

1 reference

12 December 2020

Pharmacokinetic protocol for predicting plasma nortriptyline levels

1 reference

12 December 2020

Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis

1 reference

12 December 2020

A comparison of micropuncture and lithium clearance methods in the assessment of renal tubular function in rats with diabetes insipidus

1 reference

12 December 2020

Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry

1 reference

12 December 2020

NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel

1 reference

12 December 2020

Correlates of antimanic response to carbamazepine

1 reference

12 December 2020

Child and adolescent nortriptyline single dose pharmacokinetic parameters: final report

1 reference

12 December 2020

Plasma concentrations of unbound valproate and the management of epilepsy

1 reference

12 December 2020

Lithium prophylaxis of manic-depressive disorder: daily lithium dosing schedule versus every second day

1 reference

12 December 2020

Relation of serum valproate concentration to response in mania

1 reference

12 December 2020

10.1046/J.1365-2125.2000.00174.X

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

PubMed ID

10759685